10q10k10q10k.net
SenesTech, Inc.

SenesTech, Inc.SNESEarnings & Financial Report

Nasdaq

SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.

SNES Q3 2025 Key Financial Metrics

Revenue

$690.0K

Gross Profit

$433.0K

Operating Profit

$-1.3M

Net Profit

$-1.3M

Gross Margin

62.8%

Operating Margin

-195.2%

Net Margin

-188.1%

YoY Growth

43.2%

EPS

$-0.28

Financial Flow

SenesTech, Inc. Q3 2025 Financial Summary

SenesTech, Inc. reported revenue of $690.0K for Q3 2025, with a net profit of $-1.3M (-188.1% margin). Cost of goods sold was $257.0K, operating expenses totaled $1.8M.

Key Financial Metrics

Total Revenue$690.0K
Net Profit$-1.3M
Gross Margin62.8%
Operating Margin-195.2%
Report PeriodQ3 2025

SenesTech, Inc. Annual Revenue by Year

SenesTech, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.9M).

YearAnnual Revenue
2024$1.9M
2023$1.2M
2022$1.0M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$295000$415000$459000$482000$501000$485000$625000$690000
YoY Growth-0.7%78.1%50.5%33.9%69.8%16.9%36.2%43.2%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$7.3M$5.5M$4.0M$4.4M$3.3M$3.6M$10.4M$14.6M
Liabilities$942000$862000$923000$798000$767000$734000$3.4M$3.3M
Equity$6.4M$4.6M$3.1M$3.7M$2.5M$2.9M$7.0M$11.3M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-2.0M$-1.8M$-1.6M$-1.4M$-1.2M$-1.6M$-1.1M$-1.4M